For the year ending 2025-12-31, RNXT has $8,095K in assets. $2,673K in debts. $7,024K in cash and cash equivalents.
| Balance Sheets | 2025-12-31 | |||
|---|---|---|---|---|
| Cash and cash equivalents | 7,024 | |||
| Accounts receivable | 139 | |||
| Prepaid expenses | 324 | |||
| Inventory | 189 | |||
| Other current assets | 217 | |||
| Total current assets | 7,893 | |||
| Operating lease right-of-use asset | 190 | |||
| Property and equipment, net | 12 | |||
| Total assets | 8,095 | |||
| Accounts payable | 799 | |||
| Accrued expenses and other current liabilities | 1,163 | |||
| Total current liabilities | 1,962 | |||
| Common stock warrant liability | 604 | |||
| Operating lease liability, net of current portion | 107 | |||
| Total liabilities | 2,673 | |||
| Common stock, 0.0001 par value 250,000,000 shares authorized at december 31, 2025 and 2024, respectively 36,613,916 and 24,034,672 shares issued and outstanding at december 31, 2025 and 2024, respectively | 4 | |||
| Additional paid-in capital | 66,805 | |||
| Accumulated deficit | -61,387 | |||
| Total stockholders equity | 5,422 | |||
| Total liabilities and stockholders equity | 8,095 | |||
RenovoRx, Inc. (RNXT)
RenovoRx, Inc. (RNXT)